{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:27:27Z","timestamp":1792603647086,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04227-6","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:45:39Z","timestamp":1770194739000},"page":"3075-3085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genotoxicity of cancer therapies and the risk of secondary malignancies: toward personalized prevention"],"prefix":"10.1007","volume":"28","author":[{"given":"Olorunfemi Raphael","family":"Molehin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6764-1191","authenticated-orcid":false,"given":"Amos Tomiwa","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"4227_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/bjbs.2021.10120","author":"M Abbas","year":"2022","unstructured":"Abbas M, Kushwaha V, Srivastava K, Banerjee M. Understanding role of dna repair and cytochrome p-450 gene polymorphisms in cervical cancer patient treated with concomitant chemoradiation. Br J Biomed Sci. 2022. https:\/\/doi.org\/10.3389\/bjbs.2021.10120.","journal-title":"Br J Biomed Sci"},{"key":"4227_CR2","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16344","author":"M Adamska","year":"2022","unstructured":"Adamska M, Kowal-Wi\u015bniewska E, Przyby\u0142owicz-Chalecka A, Bara\u0144ska M, \u0141ojko-Dankowska A, Joks M, et al. Clinical outcomes of therapy-related acute myeloid leukemia: over 20 years long single center retrospective analysis. Pol Arch Intern Med. 2022. https:\/\/doi.org\/10.20452\/pamw.16344.","journal-title":"Pol Arch Intern Med"},{"issue":"6","key":"4227_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0324699","volume":"20","author":"S Ahmed","year":"2025","unstructured":"Ahmed S. Ephx1 and ercc2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. PLoS One. 2025;20(6):e0324699. https:\/\/doi.org\/10.1371\/journal.pone.0324699.","journal-title":"PLoS One"},{"key":"4227_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1523693","author":"Z Ai","year":"2025","unstructured":"Ai Z, Wang B, Song Y, Cheng P, Liu X, Sun P. Prodrug-based bispecific antibodies for cancer therapy: advances and future directions. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1523693.","journal-title":"Front Immunol"},{"key":"4227_CR5","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.2147\/jmdh.s513597","volume":"18","author":"M Almutairi","year":"2025","unstructured":"Almutairi M. A cross-sectional study on the impact of nurse-led health coaching on oncology patient outcomes. J Multidiscip Healthc. 2025;18:3933\u201349. https:\/\/doi.org\/10.2147\/jmdh.s513597.","journal-title":"J Multidiscip Healthc"},{"issue":"2","key":"4227_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biology12020252","volume":"12","author":"E Baker","year":"2023","unstructured":"Baker E, San A, Cilkiz K, Littlejohn B, Cardoso R, Ghaffari N, et al. Inter-individual variation in dna methylation patterns across two tissues and leukocytes in mature Brahman cattle. Biology. 2023;12(2):252. https:\/\/doi.org\/10.3390\/biology12020252.","journal-title":"Biology"},{"issue":"2","key":"4227_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jobcr.2024.02.001","volume":"14","author":"A Bartake","year":"2024","unstructured":"Bartake A, Sarode S, Palaskar S, Girme A, Sarode G, Kamble S, et al. Evaluation of cyp1b1, oxidative stress and phase ii detoxification enzyme status in oral cancer progression model. J Oral Biol Craniofac Res. 2024;14(2):169\u201374. https:\/\/doi.org\/10.1016\/j.jobcr.2024.02.001.","journal-title":"J Oral Biol Craniofac Res"},{"issue":"14","key":"4227_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147504","volume":"22","author":"C Baudin","year":"2021","unstructured":"Baudin C, Bernier M, Klokov D, Andreassi M. Biomarkers of genotoxicity in medical workers exposed to low-dose ionizing radiation: systematic review and meta-analyses. Int J Mol Sci. 2021;22(14):7504. https:\/\/doi.org\/10.3390\/ijms22147504.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4227_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","volume":"24","author":"A Baysoy","year":"2023","unstructured":"Baysoy A, Bai Z, Satija R, Fan R. The technological landscape and applications of single-cell multi-omics. Nat Rev Mol Cell Biol. 2023;24(10):695\u2013713. https:\/\/doi.org\/10.1038\/s41580-023-00615-w.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4227_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2478\/aiht-2022-73-3600","volume":"73","author":"V Benkovi\u0107","year":"2022","unstructured":"Benkovi\u0107 V, Or\u0161oli\u0107 N, Kne\u017eevi\u0107 A, Borojevi\u0107 N, Brozovi\u0107 G, Mili\u0107 M. Kidney cell dna damage caused by combined exposure to volatile anaesthetics and 1 gy or 2 gy radiotherapy dose in vivo. Arch Ind Hyg Toxicol. 2022;73(1):62\u201370. https:\/\/doi.org\/10.2478\/aiht-2022-73-3600.","journal-title":"Arch Ind Hyg Toxicol"},{"issue":"1","key":"4227_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-251320","volume":"16","author":"B Berger","year":"2023","unstructured":"Berger B, Labriola M, Antonarakis E, Armstrong A. Response to bipolar androgen therapy and pd-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline chek2 mutation. BMJ Case Rep. 2023;16(1):e251320. https:\/\/doi.org\/10.1136\/bcr-2022-251320.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"4227_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/jgc4.1789","volume":"33","author":"D Berry","year":"2023","unstructured":"Berry D, Gillis N, Padron E, Moore C, Barton L, Gewandter K, et al. Interpretation of ambiguous tp53 test results: mosaicism, clonal hematopoiesis, and variants of uncertain significance. J Genet Couns. 2023;33(4):916\u201326. https:\/\/doi.org\/10.1002\/jgc4.1789.","journal-title":"J Genet Couns"},{"issue":"10","key":"4227_CR13","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1200\/op.20.01052","volume":"17","author":"N Bhoo-Pathy","year":"2021","unstructured":"Bhoo-Pathy N, Subramaniam S, Khalil S, Kimman M, Kong Y, Ng C, et al. Out-of-pocket costs of complementary medicine following cancer and the financial impact in a setting with universal health coverage: findings from a prospective cohort study. Jco Oncol Pract. 2021;17(10):e1592\u2013602. https:\/\/doi.org\/10.1200\/op.20.01052.","journal-title":"Jco Oncol Pract"},{"issue":"2","key":"4227_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.jaa.0000902888.46676.73","volume":"36","author":"L Bingaman","year":"2023","unstructured":"Bingaman L. The art of shared decision making. JAAPA. 2023;36(2):31\u20134. https:\/\/doi.org\/10.1097\/01.jaa.0000902888.46676.73.","journal-title":"JAAPA"},{"issue":"2","key":"4227_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103798","volume":"25","author":"Z Cai","year":"2022","unstructured":"Cai Z, Poulos R, Liu J, Zhong Q. Machine learning for multi-omics data integration in cancer. iScience. 2022;25(2):103798. https:\/\/doi.org\/10.1016\/j.isci.2022.103798.","journal-title":"iScience"},{"key":"4227_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.315","author":"C Chen","year":"2023","unstructured":"Chen C, Wang J, Pan D, Wang X, Xu Y, Yan J, et al. Applications of multi\u2010omics analysis in human diseases. Medcomm. 2023. https:\/\/doi.org\/10.1002\/mco2.315.","journal-title":"Medcomm"},{"key":"4227_CR17","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002285rr","author":"L Chiu","year":"2021","unstructured":"Chiu L, Wu N, Hung C, Bai P, Dai Y, Lin W. Parp\u20101 involves in uvb\u2010induced inflammatory response in keratinocytes and skin injury via regulation of ros\u2010dependent egfr transactivation and p38 signaling. FASEB J. 2021. https:\/\/doi.org\/10.1096\/fj.202002285rr.","journal-title":"FASEB J"},{"key":"4227_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1409300","author":"G Dagar","year":"2024","unstructured":"Dagar G, Gupta A, Shankar A, Chauhan R, Macha M, Bhat A, et al. The future of cancer treatment: combining radiotherapy with immunotherapy. Front Mol Biosci. 2024. https:\/\/doi.org\/10.3389\/fmolb.2024.1409300.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"4227_CR19","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.31557\/apjcp.2024.25.12.4281","volume":"25","author":"K Datkhile","year":"2024","unstructured":"Datkhile K, Reur P, Kale S, Gudur R, Bhosale S, Gudur A. Genetic polymorphisms of dna repair genes and their influence on paclitaxel based chemotherapy induced toxicity reactions in breast cancer patients. Asian Pac J Cancer Prev. 2024;25(12):4281\u201392. https:\/\/doi.org\/10.31557\/apjcp.2024.25.12.4281.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4227_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71896","author":"T Devika","year":"2024","unstructured":"Devika T, Mahalakshmi G, Mythili K, Rao K, Kumar S, Dubashi B, et al. Frequency distributions of alleles and genotypes and lung cancer risk of polymorphisms dck, slc29a1, and slc29a3 in south indian healthy population. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.71896.","journal-title":"Cureus"},{"issue":"W1","key":"4227_CR21","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkab405","volume":"49","author":"J Ding","year":"2021","unstructured":"Ding J, Blencowe M, Nghiem T, Ha S, Chen Y, Li G, et al. Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics. Nucl Acids Res. 2021;49(W1):W375\u201387. https:\/\/doi.org\/10.1093\/nar\/gkab405.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4227_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263086","volume":"17","author":"K Dopelt","year":"2022","unstructured":"Dopelt K, Bashkin O, Asna N, Davidovitch N. Health locus of control in cancer patient and oncologist decision-making: an exploratory qualitative study. PLoS ONE. 2022;17(1):e0263086. https:\/\/doi.org\/10.1371\/journal.pone.0263086.","journal-title":"PLoS ONE"},{"key":"4227_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05412-x","author":"H Fan","year":"2023","unstructured":"Fan H, Liu W, Zeng Y, Zhou Y, Gao M, Yang L, et al. Dna damage induced by cdk4 and cdk6 blockade triggers anti-tumor immune responses through cgas-sting pathway. Commun Biol. 2023. https:\/\/doi.org\/10.1038\/s42003-023-05412-x.","journal-title":"Commun Biol"},{"issue":"3","key":"4227_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031166","volume":"23","author":"A Filipiak-Duliban","year":"2022","unstructured":"Filipiak-Duliban A, Brodaczewska K, Kajdasz A, Ki\u00e9da C. Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and rcc models. Int J Mol Sci. 2022;23(3):1166. https:\/\/doi.org\/10.3390\/ijms23031166.","journal-title":"Int J Mol Sci"},{"key":"4227_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652049","author":"A Gupta","year":"2021","unstructured":"Gupta A, Mathew D, Bhat S, Ghoshal S, Pal A. Genetic variants of dna repair genes as predictors of radiation-induced subcutaneous fibrosis in oropharyngeal carcinoma. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.652049.","journal-title":"Front Oncol"},{"key":"4227_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13911","author":"A Halman","year":"2024","unstructured":"Halman A, Lunke S, Sadedin S, Moore C, Conyers R. Benchmarking pharmacogenomics genotyping tools: performance analysis on short\u2010read sequencing samples and depth\u2010dependent evaluation. Clin Transl Sci. 2024. https:\/\/doi.org\/10.1111\/cts.13911.","journal-title":"Clin Transl Sci"},{"key":"4227_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.629264","author":"W Hao","year":"2021","unstructured":"Hao W, Wu L, Cao L, Yu J, Li N, Wang J, et al. Radioresistant nasopharyngeal carcinoma cells exhibited decreased cisplatin sensitivity by inducing slc1a6 expression. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.629264.","journal-title":"Front Pharmacol"},{"key":"4227_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1557843","author":"X He","year":"2025","unstructured":"He X, Ge Q, Zhao W, Yu C, Bai H, Wu X, et al. Integrative multi-omics analysis and machine learning refine global histone modification features in prostate cancer. Front Mol Biosci. 2025. https:\/\/doi.org\/10.3389\/fmolb.2025.1557843.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"4227_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12071591","volume":"12","author":"S Hirano","year":"2024","unstructured":"Hirano S, Takefuji Y. Molecular hydrogen protects against various tissue injuries from side effects of anticancer drugs by reducing oxidative stress and inflammation. Biomedicines. 2024;12(7):1591. https:\/\/doi.org\/10.3390\/biomedicines12071591.","journal-title":"Biomedicines"},{"key":"4227_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci178079","author":"Q Huang","year":"2024","unstructured":"Huang Q, Tian N, Zhang J, Song S, Cheng H, Liu X, et al. Nonclassical action of ku70 promotes treg-suppressive function through a foxp3-dependent mechanism in lung adenocarcinoma. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/jci178079.","journal-title":"J Clin Invest"},{"issue":"1","key":"4227_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cpt.2024.06.007","volume":"3","author":"J Jia","year":"2025","unstructured":"Jia J, Yin J, Geng C, Liu A. Characteristics and outcomes of secondary acute lymphoblastic leukemia (sall) after multiple myeloma (mm): seer data analysis in a single-center institution. Cancer Pathog Ther. 2025;3(1):76\u201380. https:\/\/doi.org\/10.1016\/j.cpt.2024.06.007.","journal-title":"Cancer Pathog Ther"},{"key":"4227_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59266","author":"A Jivani","year":"2024","unstructured":"Jivani A, Shinde R. A comprehensive review of taxane treatment in breast cancer: clinical perspectives and toxicity profiles. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.59266.","journal-title":"Cureus"},{"key":"4227_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.47960\/2303-8616.2021.14.23","volume":"14","author":"S Karabati\u0107","year":"2021","unstructured":"Karabati\u0107 S, \u0160ajni\u0107 A, Benkovi\u0107 V, Jakopovi\u0107 M, Samard\u017eija M. A view on experience and communication perspectives in lung cancer patients in Croatia. Zdrav Glas. 2021;14:23\u201331. https:\/\/doi.org\/10.47960\/2303-8616.2021.14.23.","journal-title":"Zdrav Glas"},{"issue":"19","key":"4227_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911949","volume":"23","author":"D Karatkevich","year":"2022","unstructured":"Karatkevich D, Deng H, Gao Y, Flint E, Peng R, Schmid R, et al. Schedule-dependent treatment increases chemotherapy efficacy in malignant pleural mesothelioma. Int J Mol Sci. 2022;23(19):11949. https:\/\/doi.org\/10.3390\/ijms231911949.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4227_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/fpc.0000000000000486","volume":"33","author":"D Keller","year":"2022","unstructured":"Keller D, Medwid S, Ross C, Wigle T, Kim R. Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenet Genomics. 2022;33(1):10\u20138. https:\/\/doi.org\/10.1097\/fpc.0000000000000486.","journal-title":"Pharmacogenet Genomics"},{"issue":"24","key":"4227_CR36","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.3390\/cancers14246228","volume":"14","author":"M Khurshed","year":"2022","unstructured":"Khurshed M, Prades \u00c8, Saleh S, Sminia P, Wilmink J, Molenaar R, et al. Hyperthermia as a potential cornerstone of effective multimodality treatment with radiotherapy, cisplatin and parp inhibitor in idh1-mutated cancer cells. Cancers. 2022;14(24):6228. https:\/\/doi.org\/10.3390\/cancers14246228.","journal-title":"Cancers"},{"issue":"8","key":"4227_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084396","volume":"25","author":"H Kim","year":"2024","unstructured":"Kim H, Park J, Lee W, Kwon Y, Seu Y, Kim K. Novel amidine derivative k1586 sensitizes colorectal cancer cells to ionizing radiation by inducing chk1 instability. Int J Mol Sci. 2024;25(8):4396. https:\/\/doi.org\/10.3390\/ijms25084396.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4227_CR38","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s40262-023-01274-y","volume":"62","author":"F Kluwe","year":"2023","unstructured":"Kluwe F, Michelet R, Huisinga W, Zeitlinger M, Mikus G, Kloft C. Towards model-informed precision dosing of voriconazole: challenging published voriconazole nonlinear mixed-effects models with real-world clinical data. Clin Pharmacokinet. 2023;62(10):1461\u201377. https:\/\/doi.org\/10.1007\/s40262-023-01274-y.","journal-title":"Clin Pharmacokinet"},{"issue":"08","key":"4227_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1055\/a-2319-4179","volume":"56","author":"A Krieg","year":"2024","unstructured":"Krieg A, Krieg S, Natour O, Br\u00fcnjes S, Schott M, Kostev K. Risk of lymphoma and leukemia in thyroid cancer patients: a retrospective cohort study in Germany. Horm Metab Res. 2024;56(08):559\u201365. https:\/\/doi.org\/10.1055\/a-2319-4179.","journal-title":"Horm Metab Res"},{"key":"4227_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2024.1380928","author":"S Kumar","year":"2024","unstructured":"Kumar S, Tapken I, K\u00fchn D, Claus P, Jung K. Bootgsea: a bootstrap and rank aggregation pipeline for multi-study and multi-omics enrichment analyses. Front Bioinform. 2024. https:\/\/doi.org\/10.3389\/fbinf.2024.1380928.","journal-title":"Front Bioinform"},{"issue":"21","key":"4227_CR41","doi-asserted-by":"publisher","first-page":"13356","DOI":"10.3390\/ijms232113356","volume":"23","author":"E Lee","year":"2022","unstructured":"Lee E, Kok J, Teh B, Lim K. Interplay between the DNA damage response and immunotherapy response in cancer. Int J Mol Sci. 2022;23(21):13356. https:\/\/doi.org\/10.3390\/ijms232113356.","journal-title":"Int J Mol Sci"},{"key":"4227_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1558347","author":"Y Li","year":"2025","unstructured":"Li Y, Teng L, Wang S, Wu X, Huang T. Rare comorbidity of colon cancer, hepatic malignant mesothelioma, and abdominal Ewing\u2019s sarcoma: a case report. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1558347.","journal-title":"Front Oncol"},{"issue":"1","key":"4227_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-cancerbio-060121-120026","volume":"6","author":"A Lin","year":"2022","unstructured":"Lin A, Rauch P, Jaiswal S, Ebert B. Clonal hematopoiesis: confluence of malignant and nonmalignant diseases. Annu Rev Cancer Biol. 2022;6(1):187\u2013200. https:\/\/doi.org\/10.1146\/annurev-cancerbio-060121-120026.","journal-title":"Annu Rev Cancer Biol"},{"key":"4227_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1047684","author":"C Lin","year":"2023","unstructured":"Lin C, Hsiao S, Huang W, Tsao C, Ho C, Su S, et al. Incidence of second primary malignancies in women with different stages of breast cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2022.1047684.","journal-title":"Front Oncol"},{"key":"4227_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.685598","author":"P Lobachevsky","year":"2021","unstructured":"Lobachevsky P, Forrester H, Ivashkevich A, Mason J, Stevenson A, Hall C, et al. Synchrotron x-ray radiation-induced bystander effect: an impact of the scattered radiation, distance from the irradiated site and p53 cell status. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.685598.","journal-title":"Front Oncol"},{"key":"4227_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25328-6","author":"E Mali\u0161i\u0107","year":"2022","unstructured":"Mali\u0161i\u0107 E, Petrovi\u0107 N, Brengues M, Azria D, Mati\u0107 I, Srbljak I, et al. Association of polymorphisms in tgfb1, xrcc1, xrcc3 genes and cd8 t-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer. Sci Rep. 2022. https:\/\/doi.org\/10.1038\/s41598-022-25328-6.","journal-title":"Sci Rep"},{"issue":"2","key":"4227_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jmoldx.2020.10.014","volume":"23","author":"S McNulty","year":"2021","unstructured":"McNulty S, Evenson M, Riley M, Yoest J, Corliss M, Heusel J, et al. A next-generation sequencing test for severe congenital neutropenia. J Mol Diagn. 2021;23(2):200\u201311. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.10.014.","journal-title":"J Mol Diagn"},{"key":"4227_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1150","author":"C Moore","year":"2023","unstructured":"Moore C, Lazarakis S, Stenta T, Alexander M, Nguyen R, Elliott D, et al. A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients. Pharmacol Res Perspect. 2023. https:\/\/doi.org\/10.1002\/prp2.1150.","journal-title":"Pharmacol Res Perspect"},{"key":"4227_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70059","author":"N Naeem","year":"2025","unstructured":"Naeem N. Recent advances in 1,2,4\u2010triazole\u2010based anticancer agents: structural optimization, mechanisms, and therapeutic potential (2022\u20132025). Arch Pharm (Weinheim). 2025. https:\/\/doi.org\/10.1002\/ardp.70059.","journal-title":"Arch Pharm (Weinheim)"},{"key":"4227_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44965-z","author":"M Najafzadeh","year":"2023","unstructured":"Najafzadeh M, Naeem P, Ghaderi N, Jafarinejad S, Karimi Z, Ghaderi M, et al. Comparing p53 expression and genome-wide transcriptome profiling to comet assay in lymphocytes from melanoma patients and healthy controls. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-44965-z.","journal-title":"Sci Rep"},{"issue":"19","key":"4227_CR51","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1158\/1078-0432.ccr-24-1651","volume":"30","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Tsukada Y, Matsuhashi N, Murano T, Shiozawa M, Takahashi Y, et al. Colorectal cancer recurrence prediction using a tissue-free epigenomic minimal residual disease assay. Clin Cancer Res. 2024;30(19):4377\u201387. https:\/\/doi.org\/10.1158\/1078-0432.ccr-24-1651.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4227_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jce.16552","volume":"36","author":"A Nogueira","year":"2025","unstructured":"Nogueira A, Felix N, Kalil F, Tramujas L, Godoi A, Miyawaki I, et al. A bayesian interpretation of cabana and other randomized controlled trials for catheter ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2025;36(3):617\u201324. https:\/\/doi.org\/10.1111\/jce.16552.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"4227_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-021-00173-8","author":"M Ota","year":"2021","unstructured":"Ota M, Fujio K. Multi-omics approach to precision medicine for immune-mediated diseases. Inflamm Regen. 2021. https:\/\/doi.org\/10.1186\/s41232-021-00173-8.","journal-title":"Inflamm Regen"},{"issue":"3","key":"4227_CR54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4143\/crt.2023.843","volume":"56","author":"B Park","year":"2024","unstructured":"Park B, Lee E, Yoon J, Park Y, Eom H. Secondary malignancies in multiple myeloma in Korean patients: a nationwide population-based study. Cancer Res Treat. 2024;56(3):936\u201344. https:\/\/doi.org\/10.4143\/crt.2023.843.","journal-title":"Cancer Res Treat"},{"key":"4227_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1031325","author":"R Raciborski","year":"2022","unstructured":"Raciborski R, Woodward E, Painter J. Economic analyses of behavioral health intervention implementation: perspective on stakeholder engagement. Front Psychiatry. 2022. https:\/\/doi.org\/10.3389\/fpsyt.2022.1031325.","journal-title":"Front Psychiatry"},{"key":"4227_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2024.2428077","author":"M Salgado","year":"2024","unstructured":"Salgado M, Albarr\u00e1n V, Pozas J, Ferreiro R, Pach\u00f3n V, Longo F, et al. Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer. Future Sci Oa. 2024. https:\/\/doi.org\/10.1080\/20565623.2024.2428077.","journal-title":"Future Sci Oa"},{"issue":"11","key":"4227_CR57","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1055\/a-2423-4849","volume":"56","author":"M Schott","year":"2024","unstructured":"Schott M, Schott\u2010Ohly P, Krieg S, Thomaschky C, Wieltsch J, Petrovitch A, et al. The prognostic impact of radioiodine therapy in patients with papillary thyroid cancer. Horm Metab Res. 2024;56(11):770\u20138. https:\/\/doi.org\/10.1055\/a-2423-4849.","journal-title":"Horm Metab Res"},{"issue":"5","key":"4227_CR58","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/sla.0000000000006090","volume":"279","author":"A Shannon","year":"2023","unstructured":"Shannon A, Sarna A, Bressler L, Monsour C, Palettas M, Huang E, et al. Quality of life and real-time patient experience during neoadjuvant therapy. Ann Surg. 2023;279(5):850\u20136. https:\/\/doi.org\/10.1097\/sla.0000000000006090.","journal-title":"Ann Surg"},{"issue":"6","key":"4227_CR59","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/1878-0261.70000","volume":"19","author":"Y Song","year":"2025","unstructured":"Song Y, Wang Z, Zhang G, Hou J, Liu K, Wei S, et al. Classification of acute myeloid leukemia based on multi\u2010omics and prognosis prediction value. Mol Oncol. 2025;19(6):1836\u201354. https:\/\/doi.org\/10.1002\/1878-0261.70000.","journal-title":"Mol Oncol"},{"issue":"5","key":"4227_CR60","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00044-022-02862-6","volume":"31","author":"Y Song","year":"2022","unstructured":"Song Y, Zhu X, Yang K, Feng S, Zhang Y, Dong J, et al. Synthesis and biological evaluation of xanthone derivatives as anti-cancer agents targeting topoisomerase ii and dna. Med Chem Res. 2022;31(5):720\u201334. https:\/\/doi.org\/10.1007\/s00044-022-02862-6.","journal-title":"Med Chem Res"},{"issue":"1","key":"4227_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.54457\/dr.202402015","volume":"5","author":"L Swain","year":"2025","unstructured":"Swain L, Das B, Baran N. Multifaced anticancer potential of doxorubicin: spotlight on breast cancer. Disabil Res. 2025;5(1):19\u201336. https:\/\/doi.org\/10.54457\/dr.202402015.","journal-title":"Disabil Res"},{"key":"4227_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/ceor.s489929","volume":"17","author":"B Talente","year":"2025","unstructured":"Talente B, Finseth L, Blake N, Costello K, Schmidt H, Vandigo J, et al. Patient experiences with the impacts of multiple sclerosis & disease-modifying therapies. Clinicoecon Outcomes Res. 2025;17:199\u2013215. https:\/\/doi.org\/10.2147\/ceor.s489929.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"4227_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062757","volume":"26","author":"M Tariq","year":"2025","unstructured":"Tariq M, Advani D, Almansoori B, AlSamahi M, Aldhaheri M, Alkaabi S, et al. The identification of novel therapeutic biomarkers in rheumatoid arthritis: a combined bioinformatics and integrated multi-omics approach. Int J Mol Sci. 2025;26(6):2757. https:\/\/doi.org\/10.3390\/ijms26062757.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4227_CR64","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41416-024-02706-7","volume":"131","author":"N Valous","year":"2024","unstructured":"Valous N, Popp F, Z\u00f6rnig I, J\u00e4ger D, Charoentong P. Graph machine learning for integrated multi-omics analysis. Br J Cancer. 2024;131(2):205\u201311. https:\/\/doi.org\/10.1038\/s41416-024-02706-7.","journal-title":"Br J Cancer"},{"issue":"5","key":"4227_CR65","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/10781552211073967","volume":"28","author":"U Vusqa","year":"2022","unstructured":"Vusqa U, Chahine Z, Asawa P, Sadashiv S, Samhouri Y, Lister J. Three cases of lenalidomide therapy for multiple myeloma and subsequent development of secondary b-all. J Oncol Pharm Pract. 2022;28(5):1214\u20137. https:\/\/doi.org\/10.1177\/10781552211073967.","journal-title":"J Oncol Pharm Pract"},{"issue":"17","key":"4227_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36155","volume":"10","author":"T Wang","year":"2024","unstructured":"Wang T, Cui S, Lyu C, Wang Z, Li Z, Chen H, et al. Molecular precision medicine: multi-omics-based stratification model for acute myeloid leukemia. Heliyon. 2024;10(17):e36155. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36155.","journal-title":"Heliyon"},{"key":"4227_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04029-3","author":"Y Wen","year":"2021","unstructured":"Wen Y, Song X, Yan B, Yang X, Wu L, Leng D, et al. Multi-dimensional data integration algorithm based on random walk with restart. BMC Bioinformatics. 2021. https:\/\/doi.org\/10.1186\/s12859-021-04029-3.","journal-title":"BMC Bioinformatics"},{"key":"4227_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29499","author":"A Wintering","year":"2021","unstructured":"Wintering A, Smith S, Fuh B, Rangaswami A, Dahl G, Chien M, et al. Therapy\u2010related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature. Pediatr Blood Cancer. 2021. https:\/\/doi.org\/10.1002\/pbc.29499.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"4227_CR69","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1111\/cas.15447","volume":"113","author":"A Wu","year":"2022","unstructured":"Wu A, Liu J, Zhang X, Niu C, Shu G, Yin G. Comprehensive network analysis of dysregulated genes revealed mnx1-as1\/hsa-mir-4697-3p\/hoxb13 axis in ovarian cancer chemotherapy response. Cancer Sci. 2022;113(8):2627\u201341. https:\/\/doi.org\/10.1111\/cas.15447.","journal-title":"Cancer Sci"},{"issue":"3","key":"4227_CR70","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10549-021-06292-7","volume":"189","author":"J Xu","year":"2021","unstructured":"Xu J, Keenan T, Overmoyer B, Tung N, Gelman R, Habin K, et al. Phase ii trial of veliparib and temozolomide in metastatic breast cancer patients with and without brca1\/2 mutations. Breast Cancer Res Treat. 2021;189(3):641\u201351. https:\/\/doi.org\/10.1007\/s10549-021-06292-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"4227_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094268","volume":"26","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wu J, Chen C, Ouyang J, Li D, Shi T. Emitool: explainable multi-omics integration for disease subtyping. Int J Mol Sci. 2025;26(9):4268. https:\/\/doi.org\/10.3390\/ijms26094268.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4227_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/iju.70032","volume":"32","author":"S Yajima","year":"2025","unstructured":"Yajima S, Hata S, Masumori N, Matsuoka Y, Sawada A, Miki J, et al. Patient preferences for post\u2010radical cystectomy treatment in muscle\u2010invasive bladder cancer: a discrete choice experiment in Japan. Int J Urol. 2025;32(6):688\u201397. https:\/\/doi.org\/10.1111\/iju.70032.","journal-title":"Int J Urol"},{"key":"4227_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70301","author":"Z Yao","year":"2025","unstructured":"Yao Z. Influence of genetic variation of gst, cyp, and abc on the safety and efficacy of cyclophosphamide\u2010based therapy. Clin Transl Sci. 2025. https:\/\/doi.org\/10.1111\/cts.70301.","journal-title":"Clin Transl Sci"},{"key":"4227_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1093326","author":"M Yaz\u0131c\u0131","year":"2023","unstructured":"Yaz\u0131c\u0131 M, Marron J, Bak\u0131r-G\u00fcng\u00f6r B, Zou F, Yousef M. Invention of 3mint for feature grouping and scoring in multi-omics. Front Genet. 2023. https:\/\/doi.org\/10.3389\/fgene.2023.1093326.","journal-title":"Front Genet"},{"issue":"6","key":"4227_CR75","doi-asserted-by":"publisher","first-page":"366","DOI":"10.55730\/1300-0152.2671","volume":"47","author":"M Yousef","year":"2023","unstructured":"Yousef M, Allmer J. Deep learning in bioinformatics. Turk J Biol. 2023;47(6):366\u201382. https:\/\/doi.org\/10.55730\/1300-0152.2671.","journal-title":"Turk J Biol"},{"issue":"4","key":"4227_CR76","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1039\/d2mo00220e","volume":"19","author":"P Yue","year":"2023","unstructured":"Yue P, Han B, Zhao Y. Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches. Mol Omics. 2023;19(4):297\u2013307. https:\/\/doi.org\/10.1039\/d2mo00220e.","journal-title":"Mol Omics"},{"key":"4227_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-023-00458-8","author":"J Yun","year":"2023","unstructured":"Yun J, Song H, Kim S, Kim S, Kwon S, Lee Y, et al. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea. Hum Genomics. 2023. https:\/\/doi.org\/10.1186\/s40246-023-00458-8.","journal-title":"Hum Genomics"},{"key":"4227_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.3050","author":"M Zaid","year":"2023","unstructured":"Zaid M, Dalm\u0131zrak \u00d6, Teral\u0131 K, \u00d6zer N. Mechanistic insights into the inhibition of human placental glutathione s-transferase p1\u20131 by abscisic and gibberellic acids: an integrated experimental and computational study. J Mol Recognit. 2023. https:\/\/doi.org\/10.1002\/jmr.3050.","journal-title":"J Mol Recognit"},{"key":"4227_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1005522","author":"X Zhang","year":"2022","unstructured":"Zhang X, Luo M, Zhang J, Guo B, Singh S, Lin X, et al. The role of lncrna h19 in tumorigenesis and drug resistance of human cancers. Front Genet. 2022. https:\/\/doi.org\/10.3389\/fgene.2022.1005522.","journal-title":"Front Genet"},{"issue":"7","key":"4227_CR80","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/cas.70081","volume":"116","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Hisayoshi T, Zhang D, Suzuki S, Watanabe T, Kobayashi A, et al. Steroid\u2010modulated transcription synergistically forms dna double\u2010strand breaks with topoisomerase ii inhibitor. Cancer Sci. 2025;116(7):1952\u201362. https:\/\/doi.org\/10.1111\/cas.70081.","journal-title":"Cancer Sci"},{"issue":"22","key":"4227_CR81","doi-asserted-by":"publisher","first-page":"12207","DOI":"10.1093\/nar\/gkad940","volume":"51","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Hou K, Li Y, Hao S, Liu Y, Na Y, et al. Human helq regulates DNA end resection at DNA double-strand breaks and stalled replication forks. Nucleic Acids Res. 2023;51(22):12207\u201323. https:\/\/doi.org\/10.1093\/nar\/gkad940.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4227_CR82","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/1940-6207.capr-20-0524","volume":"14","author":"X Zhu","year":"2021","unstructured":"Zhu X, Parks P, Weiser E, Fischer K, Griffin J, Limburg P, et al. National survey of patient factors associated with colorectal cancer screening preferences. Cancer Prev Res. 2021;14(5):603\u201314. https:\/\/doi.org\/10.1158\/1940-6207.capr-20-0524.","journal-title":"Cancer Prev Res"},{"key":"4227_CR83","doi-asserted-by":"publisher","DOI":"10.1159\/000537866","author":"S Zou","year":"2024","unstructured":"Zou S, Chen J, Zhou P, Xue M, Wu M, Wang L. Multi-omics integrated analysis of the protective effect of ezh2 inhibition in mice with renal ischemia-reperfusion injury. Kidney Blood Press Res. 2024. https:\/\/doi.org\/10.1159\/000537866.","journal-title":"Kidney Blood Press Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04227-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:28:55Z","timestamp":1784975335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04227-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":83,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["4227"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04227-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I declare that the authors have no competing interests as defined by Springer, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration (from you or one of your contributing authors) by another publisher.","order":2,"name":"Ethics","label":"Dual publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I have read the Nature Portfolio journal policies on author responsibilities and submit this manuscript in accordance with those policies.","order":3,"name":"Ethics","label":"Authorship","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the materials are owned by the authors and\/or no permissions are required.","order":4,"name":"Ethics","label":"Third party material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is a review paper and it does not involve any research involving human participants and\/or animals. Hence there is no need for Ethical approval","order":5,"name":"Ethics","label":"Ethical approval (Research involving human participants and\/or animals), Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}